Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 11, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.5K

Newborn screening.

Susan A Berry1

  • 1Department of Pediatrics, University of Minnesota, 420 Delaware Street Southeast MMC75, Minneapolis, MN 55455, USA.

Clinics in Perinatology
|June 5, 2015
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

The PKU Patient Registry: Development of a patient-driven registry and initial outcomes.

Molecular genetics and metabolism·2025
Same author

Maternal health outcomes in ornithine transcarbamylase deficiency: A comparative analysis of pregnancies in symptomatic and asymptomatic heterozygotes.

Molecular genetics and metabolism·2025
Same author

Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).

Genetics in medicine : official journal of the American College of Medical Genetics·2024
Same author

Access to Dietary Treatment for Inborn Errors of Metabolism: You Do Not Get What You Do Not Pay For.

JAMA network open·2024
Same author

Understanding patient, caregiver, and healthcare provider perspectives of the management of long-chain fatty acid oxidation disorders.

Therapeutic advances in rare disease·2024
Same journal

Breathing Physiology into the Art of Neonatal Respiratory Care.

Clinics in perinatology·2026
Same journal

The Science and Art of Neonatal Respiratory Care.

Clinics in perinatology·2026
Same journal

Ex Utero Artificial Womb Support: Promising Future for Extremely Preterm Infants.

Clinics in perinatology·2026
Same journal

Advances in the Use of Cell-Based Therapies for Prevention of Bronchopulmonary Dysplasia.

Clinics in perinatology·2026
Same journal

Evaluation and Management of Genetic Respiratory Disorders Presenting as Hypoxemic Respiratory Failure in the Newborn Infant.

Clinics in perinatology·2026
Same journal

Modern Surfactant Delivery Methods with a Focus on Implementation of Surfactant Administration Through Laryngeal and Supraglottic Airways.

Clinics in perinatology·2026
See all related articles

Newborn screening identifies serious health conditions in infants. Adding new tests requires a scientific, evidence-based approach to reduce infant illness and death.

Area of Science:

  • Public Health
  • Neonatology
  • Genetics

Background:

  • Newborn screening is a critical public health initiative.
  • All infants undergo screening for conditions not apparent at birth.
  • The goal is to decrease infant morbidity and mortality.

Purpose of the Study:

  • To emphasize the importance of evidence-based processes for adding new conditions to newborn screening panels.
  • To highlight the role of neonatologists in ensuring infants receive this vital testing.
  • To advocate for consideration of social, legal, and ethical factors in expanding newborn screening.

Main Methods:

  • Review of current newborn screening practices.
  • Analysis of the scientific basis for condition inclusion.
Keywords:
Critical congenital heart diseaseEarly hearing detection and interventionInherited metabolic disordersNewborn screening

More Related Videos

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants
11:39

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants

Published on: March 14, 2013

21.2K
Transcutaneous Microcirculatory Imaging in Preterm Neonates
06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

8.6K

Related Experiment Videos

Last Updated: Apr 11, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.5K
Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants
11:39

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants

Published on: March 14, 2013

21.2K
Transcutaneous Microcirculatory Imaging in Preterm Neonates
06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

8.6K
  • Discussion of stakeholder roles and ethical considerations.

    • Main Results:

    • Newborn screening is a successful public health program.
    • A systematic, evidence-based approach is crucial for adding new screening conditions.
    • Collaboration among various partners, including neonatologists, is essential.

    Conclusions:

    • Newborn screening effectively reduces infant morbidity and mortality.
    • The process for adding conditions must be scientific and evidence-based.
    • Addressing social, legal, and ethical issues can enhance the scope of newborn screening.